López-Guillermo A - Search Results

1

CDK4 and MDM2 gene alterations mainly occur in highly proliferative and aggressive mantle cell lymphomas with wild-type INK4a/ARF locus.

Hernández L, Beà S, Pinyol M, Ott G, Katzenberger T, Rosenwald A, Bosch F, López-Guillermo A, Delabie J, Colomer D, Montserrat E, Campo E. Hernández L, et al. Cancer Res. 2005 Mar 15;65(6):2199-206. doi: 10.1158/0008-5472.CAN-04-1526. Cancer Res. 2005. PMID: 15781632

2

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.

Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, Gascoyne RD, Muller-Hermelink HK, Smeland EB, Giltnane JM, Hurt EM, Zhao H, Averett L, Yang L, Wilson WH, Jaffe ES, Simon R, Klausner RD, Powell J, Duffey PL, Longo DL, Greiner TC, Weisenburger DD, Sanger WG, Dave BJ, Lynch JC, Vose J, Armitage JO, Montserrat E, López-Guillermo A, Grogan TM, Miller TP, LeBlanc M, Ott G, Kvaloy S, Delabie J, Holte H, Krajci P, Stokke T, Staudt LM; Lymphoma/Leukemia Molecular Profiling Project. Rosenwald A, et al. N Engl J Med. 2002 Jun 20;346(25):1937-47. doi: 10.1056/NEJMoa012914. N Engl J Med. 2002. PMID: 12075054 Free article.

3

Genetic imbalances in progressed B-cell chronic lymphocytic leukemia and transformed large-cell lymphoma (Richter's syndrome).

Beà S, López-Guillermo A, Ribas M, Puig X, Pinyol M, Carrió A, Zamora L, Soler F, Bosch F, Stilgenbauer S, Colomer D, Miró R, Montserrat E, Campo E. Beà S, et al. Am J Pathol. 2002 Sep;161(3):957-68. doi: 10.1016/S0002-9440(10)64256-3. Am J Pathol. 2002. PMID: 12213724 Free PMC article.

4

High-dose infusional ifosfamide, etoposide plus methylprednisolone followed by dexamethasone, high-dose ara-C and cisplatinum and autologous stem cell transplantation for refractory or relapsed aggressive non-Hodgkin's lymphoma.

Salar A, Martino R, Perea G, Ribera JM, López-Guillermo A, Guardia R, Escoda L, Altés A, Sierra J, Montserrat E. Salar A, et al. Haematologica. 2002 Oct;87(10):1028-35. Haematologica. 2002. PMID: 12368156

5

Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma.

Colomo L, López-Guillermo A, Perales M, Rives S, Martínez A, Bosch F, Colomer D, Falini B, Montserrat E, Campo E. Colomo L, et al. Blood. 2003 Jan 1;101(1):78-84. doi: 10.1182/blood-2002-04-1286. Epub 2002 Aug 8. Blood. 2003. PMID: 12393466 Free article.

6

CHK2-decreased protein expression and infrequent genetic alterations mainly occur in aggressive types of non-Hodgkin lymphomas.

Tort F, Hernàndez S, Beà S, Martínez A, Esteller M, Herman JG, Puig X, Camacho E, Sánchez M, Nayach I, Lopez-Guillermo A, Fernández PL, Colomer D, Hernàndez L, Campo E. Tort F, et al. Blood. 2002 Dec 15;100(13):4602-8. doi: 10.1182/blood-2002-04-1078. Epub 2002 Aug 1. Blood. 2002. PMID: 12393693 Free article.

7

Fludarabine, cyclophosphamide and mitoxantrone in the treatment of resistant or relapsed chronic lymphocytic leukaemia.

Bosch F, Ferrer A, López-Guillermo A, Giné E, Bellosillo B, Villamor N, Colomer D, Cobo F, Perales M, Esteve J, Altés A, Besalduch J, Ribera JM, Montserrat E; GELCAB (Grup per l'Estudi dels Limfomes a Catalunya i Balears). Bosch F, et al. Br J Haematol. 2002 Dec;119(4):976-84. doi: 10.1046/j.1365-2141.2002.03959.x. Br J Haematol. 2002. PMID: 12472576 Free article. Clinical Trial.

8

Salvage treatment with etoposide (VP-16), ifosfamide and cytarabine (Ara-C) for patients with recurrent primary central nervous system lymphoma.

Arellano-Rodrigo E, López-Guillermo A, Bessell EM, Nomdedeu B, Montserrat E, Graus F. Arellano-Rodrigo E, et al. Eur J Haematol. 2003 Apr;70(4):219-24. doi: 10.1034/j.1600-0609.2003.00045.x. Eur J Haematol. 2003. PMID: 12656744

9

Incidence and clinical significance of bcl-2/IgH rearrangements in follicular lymphoma.

Montoto S, López-Guillermo A, Colomer D, Esteve J, Bosch F, Ferrer A, Villamor N, Moreno C, Campo E, Montserrat E. Montoto S, et al. Leuk Lymphoma. 2003 Jan;44(1):71-6. doi: 10.1080/1042819021000050052. Leuk Lymphoma. 2003. PMID: 12691144

10

ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.

Crespo M, Bosch F, Villamor N, Bellosillo B, Colomer D, Rozman M, Marcé S, López-Guillermo A, Campo E, Montserrat E. Crespo M, et al. N Engl J Med. 2003 May 1;348(18):1764-75. doi: 10.1056/NEJMoa023143. N Engl J Med. 2003. PMID: 12724482 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

423 results

Search Page

Filters